Xeomin 200 unidades pó para solução injetável clinical trials

An exploratory, prospective, multicenter, randomized, double blind, placebo + sham device controlled, study to assess the safety, usability, and initial efficacy of the ViXe combination for intravesical administration of XEOMIN® in the treatment of female patients with idiopathic overactive bladder (OAB).

This study is looking at a new treatment called ViXe, which combines two medicines, for women with overactive bladder. It checks if the treatment is safe, easy to use, and if it helps reduce symptoms like needing to pee urgently or leaking urine.